Efficacy and Safety Results of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Results From SPROUT, a Phase 3, Randomized, Controlled Study. J of Skin. 2023;7(2):s109. doi:10.25251/skin.7.supp.109